| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/30/2005 | US6936596 Adenosine derivatives and use thereof |
| 08/30/2005 | CA2136331C New pharmaceutical uses of krill enzymes |
| 08/30/2005 | CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/25/2005 | WO2005077971A1 Novel heparin-binding peptide designed from heparin-binding site of snake poison-origin vascular endothelial growth factor (vegf)-like protein and use tehreof |
| 08/25/2005 | WO2005077970A1 Novel heparin-binding peptide designed from heparin-binding site of snake venom-origin vascular endothelial growth factor (vegf)-like protein and use thereof |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR |
| 08/25/2005 | US20050187380 Method for treating Th2-mediated disease |
| 08/25/2005 | US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187236 Nitrogen-containing aromatic derivatives |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/25/2005 | US20050186665 Expressed ligand - vascular intercellular signaling molecule |
| 08/25/2005 | US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186280 Carbopol" carboxy vinyl polymer stabilizer; topical formulations for eyes or skin; cream, ointment, gel, patches; drugs, cosmetics |
| 08/25/2005 | US20050186279 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 08/25/2005 | DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I |
| 08/25/2005 | CA2556601A1 The use of o-atp for the treatment of diseases involving angiogenesis |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1566184A1 Remedy for corneal failure |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 08/24/2005 | EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 08/24/2005 | EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1360185B1 Carboline derivatives |
| 08/24/2005 | EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 08/24/2005 | EP1335917B1 Condensed pyridoindole derivatives |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1263742B1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | CN1659183A Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 08/24/2005 | CN1659161A Piperidine derivatives having CCR3 antagonism |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 08/24/2005 | CN1657539A Human connective tissue growth factor mutant protein and its application |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1216034C Malic acid addition salts of terbinafine |
| 08/24/2005 | CN1215844C Gatifloxacin gels for eye and its preparing method |
| 08/23/2005 | US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933305 Amide compounds and use thereof |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | CA2370888C Renin inhibitors |
| 08/23/2005 | CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties |
| 08/23/2005 | CA2119782C Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
| 08/18/2005 | WO2005074942A1 Slow release steroid composition |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | WO2005074907A1 Gene expression controlling agent |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182093 Novel compounds |
| 08/18/2005 | US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents |
| 08/18/2005 | US20050182057 Aryl N-cyanoguanidines and methods related thereto |
| 08/18/2005 | US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181054 comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm; efficient penetration and high permeability blood at the mucosa |
| 08/18/2005 | US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 08/18/2005 | US20050181018 Ocular drug delivery |
| 08/18/2005 | CA2558877A1 Solifenacin succinate-containing composition |
| 08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
| 08/17/2005 | EP1563845A1 Remedies for allergic diseases |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562909A1 Ophthalmic compositions for treating ocular hypertension |
| 08/17/2005 | EP1562906A2 Heterocyclic selective androgen receptor modulators and methods of use thereof |
| 08/17/2005 | EP1562597A2 Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| 08/17/2005 | EP1562592A2 Histone deacetylase inhibitors for treating degenerative diseases of the eye |
| 08/17/2005 | EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 08/17/2005 | EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 08/17/2005 | EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1087943B1 Therapeutic biaryl derivatives |
| 08/17/2005 | EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
| 08/17/2005 | CN1656084A Hydroxymorpholinone derivative and medicinal use thereof |
| 08/17/2005 | CN1656065A Ligand as the RAR receptor inhibitor |
| 08/17/2005 | CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin |